Weight Loss Clinical Trial
Official title:
Investigating the Effects of Two Weeks of 5:2 Intermittent Energy Restriction or Continuous Energy Restriction on Basal and Postprandial Metabolism in Normal-weight, Young Participants
Worldwide, a third of adults were overweight in 2016, and 13% were obese. Excess energy intake results in weight gain. Excess fat increases the risk of disease (eg. cardiovascular diseases, type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, dementia, certain cancers). Modest weight reduction (>5% of body weight) decreases the incidence and progression of many of these diseases. Daily energy restriction or continuous energy restriction (CER) involves diets that have a 500-600 kcal deficit per day resulting in sustainable weight loss. However, adherence is difficult. Diets following a 5:2 intermittent energy restriction (5:2 IER) pattern may be better. Approximately 75% energy restriction is maintained for 2 non-consecutive days/week and normal energy intake is consumed on the remaining 5 days of the week. Significantly reduced fasting insulin concentration and insulin resistance were shown in the 5:2 IER regimen compared with the CER regimen. In this study, normal-weight young participants will be recruited and 5:2 IER and CER will be compared over 2 week periods. Subcutaneous continuous glucose monitoring (CGM) devices will be undertaken. An ad libitum pasta meal will be consumed by participants three hours after the ingestion of breakfast to evaluate the energy intake. Postprandial thermogenesis in response to the test drink will be evaluated.
Once participants have consented to be screened, they will come to the lab for a medical
screening. If the medical screening is satisfactory, all participants will be asked to
undergo a one-week pre-study standardization period. Participants will be asked to maintain
their normal dietary and physical activity patterns throughout this period. Participants will
be asked to complete a 3-day food diary, which will be analyzed to evaluate their habitual
food intake and temporal distribution of energy intake throughout the day. In addition,
participants will be provided with and instructed on how to use, an Actiheart (a device that
combines accelerometry with heart rate monitoring). This device will be placed on the
participants' chest using two standard electrocardiogram (ECG) electrodes to record HR, heart
rate variability and activity level (to allow estimation of total energy expenditure) for one
week. Both items will be returned before the next visit, which will be the pre-intervention
measurement. After the pre-intervention visit, participants will be then randomly assigned to
two weeks of either (1) the CER of 20% restriction below their estimated requirement (~1600
kcal) 7 days/week or (2) the 5:2 IER of 70% restriction (~600 kcal) delivered for two
non-consecutive days/week and no restriction (so sufficient energy to meet their requirement)
on the other 5 days/week. Seven days after the pre-intervention visit, participants will then
start their 2-week intervention. A 7-day gap is designed in a bid to ensure both pre- and
post-intervention measurements will be conducted during the second week of the follicular
phase for females. The foods, drinks and overall energy restriction will be the same on each
arm. Using estimated BMR based on the Henry equation and the individual daily physical
activity level (PAL), estimated from the Actiheart during a one-week standardization period
and the physical activity questionnaire, allowed the estimation of daily energy requirements
for each subject using basal metabolic rate x PAL. Thus energy intake will be tailored to
each participant's specific energy requirements. According to the suggestion from The
Association of UK Dietitians, 2 non-consecutive ER days can be achieved on Day 1 and Day 4 of
an IER week, thus the investigators will fix and prescribed the two ER days in a week with 3
days apart.
Food on intervention days will be prepared based on a 3-day sequence of menus to avoid
boredom but be practical regarding the provision of foods. Each menu provides three meals/day
to avoid confounding effects causing by altering meal frequency between the interventions.
Three meals/day (and no snacks) is selected to make each eating incident acceptable on the
most restricted day. Three meals with a macronutrient distribution of ~50% energy from
carbohydrates, ~31% from fat and ~19% from protein will be prescribed. The distribution of
energy across the day will be 25% of daily energy requirements from breakfast, 37.5% from
lunch and 37.5% from the evening meal. To avoid confounding by altering the mealtime, and the
period between which meals are consumed, breakfast will be instructed to be consumed between
8 am-8:30 am; lunch between 1 pm-1:30 pm and evening meal between 6 pm-6.30 pm. Menu designed
so that it could be proportionally increased and decreased depending on the intervention
requirement and informed by cooking facilities available and optimizing food safety.
Participants will be instructed to adhere to the prescribed meal plan and record their food
intake by taking photos.
On Day 7 of each experimental trial, participants will report to the unit in the morning
after an overnight fast (~12h) for the assessment of body weight. The investigators will also
use this visit to attach a subcutaneous continuous glucose monitoring (CGM) device, which
will be placed on the abdomen to allow for the estimation of continuous blood glucose over
the last 7 days of each trial. Also, the investigators will download the data from the
pedometer and use it to assess compliance with the requirements of the study during the first
week. CGM and pedometer will be removed upon arrival on the post-intervention visit.
On the day after one week pre-study standardization period and the day after the 2-week
intervention, the participants will be asked to attend the laboratory after an overnight fast
to undergo a series of appetite and metabolic measurements in response to a standardised
breakfast in the form of a milk-based test drink (in a volume of 10 kcal/kg body weight and
energy distribution from the macronutrients will be 47.9 % carbohydrate, 35.1% fat, and 17%
protein) and a subsequent ad libitum pasta lunch containing cheese, olive oil, and tomato
sauce, which will provide 148.24 kcal/100g with 49.8%, 15.4% and 34.8% energy provided by
carbohydrates, protein and fat, respectively.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Terminated |
NCT03316105 -
Effect of T6 Dermatome Electrical Stimulation on Gastroduodenal Motility in Healthy Volunteers
|
N/A | |
Completed |
NCT03700736 -
The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups
|
N/A | |
Active, not recruiting |
NCT04353726 -
Knowledge-based Dietary Weight Management.
|
N/A | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03377244 -
Healthy Body Healthy Souls in the Marshallese Population
|
N/A | |
Completed |
NCT02877004 -
LLLT for Reducing Waste Circumference and Weight
|
N/A | |
Active, not recruiting |
NCT04327141 -
Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women
|
N/A | |
Completed |
NCT03929198 -
Translation of Pritikin Program to the Community
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Recruiting |
NCT05942326 -
Sleep Goal-focused Online Access to Lifestyle Support
|
N/A | |
Completed |
NCT00535600 -
Effects of Bariatric Surgery on Insulin
|
||
Not yet recruiting |
NCT03601273 -
Bariatric Embolization Trial for the Obese Nonsurgical
|
Phase 1 | |
Active, not recruiting |
NCT04357119 -
Common Limb Length in One-anastomosis Gastric Bypass
|
N/A | |
Completed |
NCT03139760 -
POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability
|
N/A | |
Completed |
NCT02948517 -
Time Restricted Feeding for Weight Loss and Cardio-protection
|
N/A | |
Completed |
NCT03210207 -
Gastric Plication in Mexican Patients
|
N/A | |
Completed |
NCT02945410 -
Effect of Caloric Restriction and Protein Intake on Metabolism and Anabolic Sensitivity
|
N/A | |
Recruiting |
NCT02559479 -
A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes
|
N/A |